Optimal Light Dose for hEGFR-Targeted Near-Infrared Photoimmunotherapy.
Furumoto H, Okada R, Kato T, Wakiyama H, Inagaki F, Fukushima H, Okuyama S, Furusawa A, Choyke PL, Kobayashi H.
Furumoto H, et al.
Cancers (Basel). 2022 Aug 22;14(16):4042. doi: 10.3390/cancers14164042.
Cancers (Basel). 2022.
PMID: 36011036
Free PMC article.